Quantoom Biosciences Sa
Quantoom Biosciences SA, headquartered in Belgium, is a pioneering company in the biotechnology sector, specialising in advanced quantum technologies for life sciences. Founded in recent years, Quantoom has quickly established itself as a leader in the development of innovative solutions that enhance drug discovery and diagnostics. The company focuses on harnessing quantum computing and artificial intelligence to revolutionise the way biological data is processed and analysed. Their unique approach allows for unprecedented accuracy and efficiency in research, setting them apart in a competitive market. With a commitment to pushing the boundaries of science, Quantoom Biosciences has achieved significant milestones, positioning itself as a key player in the biotechnology landscape. Their cutting-edge products and services are designed to meet the evolving needs of researchers and healthcare professionals worldwide.
DitchCarbon Score
How does Quantoom Biosciences Sa's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Quantoom Biosciences Sa's score of 27 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Quantoom Biosciences Sa's reported carbon emissions
In 2023, Quantoom Biosciences Sa reported significant carbon emissions, with Scope 2 emissions totalling approximately 64,000,000 kg CO2e (market-based) and 240,000,000 kg CO2e (location-based). Additionally, their Scope 3 emissions reached about 8,995,000,000 kg CO2e. The company has shown a commitment to reducing its carbon footprint, as evidenced by a decrease in Scope 2 emissions from 88,000,000 kg CO2e in 2022 to the 2023 figures. Looking ahead to 2024, Quantoom's Scope 2 emissions are projected to be around 444,000,000 kg CO2e (location-based), while Scope 3 emissions are expected to be approximately 8,983,000,000 kg CO2e. Despite these figures, there are currently no specific reduction targets or initiatives disclosed by the company, indicating a potential area for future commitment to climate action. Overall, Quantoom Biosciences Sa's emissions data highlights the scale of their carbon footprint, particularly in Scope 3 emissions, and underscores the importance of establishing clear reduction targets to align with industry standards for climate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | 88,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | - | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quantoom Biosciences Sa is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
